CompletedNot Applicable

Diagnosis of Epithelial Ovarian Cancer Using Ovarian Cancer Score (OCS) Test

China1,352 participantsStarted 2019-10-09

Plain-language summary

The study is designed to confirm the performance of the 3D Medicines Corporation OCS test in diagnosis of epithelial ovarian cancer in patients with adnexal mass. To this end, blood samples from female patients with adnexal mass required surgical resection from four centers are obtained and analysis in the study.

Who can participate

Age range

18 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * a) ≥ 18 years of age; * b) Patients with adnexal masses; * c) Sign the informed consent form; * d) Adnexal mass that requires excision; Exclusion Criteria: * a) history of chemoradiotherapy; * b) history of malignancy; * c) pregnancy; * d) Adnexal mass not require surgical excision; * e) The adnexal mass has been diagnosed as malignant before surgery, and the number of cases enrolled in a single institution exceeds 50; * f) Blood CA125 value greater than 1000 U/ml at initial treatment.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

the Performance of Discrimination of Benign Disease and Malignant tumors by the OCS Value.

Timeframe: Data analysis would be completed in three months after all data were collected.

Trial details

NCT IDNCT06366997

SponsorChongqing University Cancer Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-04-18

View on ClinicalTrials.gov More Epithelial Ovarian Cancer trials